Effects of angiogenic growth factors on endothelium-derived prostacyclin production by ovine uterine and placental arteries

被引:16
作者
Krishnamurthy, P
Bird, IM
Sheppard, C
Magness, RR
机构
[1] Univ Wisconsin, Dept Obstet & Gynecol, Perinatal Res Labs, Madison, WI 53715 USA
[2] Univ Wisconsin, Dept Meat & Anim Sci, Madison, WI 53715 USA
关键词
angiogenesis; pregnancy; blood vessels; vascular smooth muscle; blood flow;
D O I
10.1016/S0090-6980(98)00066-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Uteroplacental and fetoplacental arteries produce substantial amounts of prostacyclin (PGI(2)). Because angiogenic growth factors such as basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF) are increased in pregnancy, we hypothesized that treatment of uterine and fetoplacental arteries with bFGF, VEGF, and EGF would further enhance the pregnancy-induced increase in PGI(2) production. Duplicate uterine (UA) and fetoplacental (PA) artery (primary branch off of the umbilical cord = pPA; cotyledonary or tertiary = tPA) explants from seven late gestation sheep were placed in tissue culture (RPMI; 37 degrees C) for 24 h alone or with (1-100 ng/mL) bFGF, VEGF, or EGF. To evaluate the endothelial contribution to basal and stimulated PGI(2) production and to determine whether it is de novo, arteries with and without endothelium from three additional late gestation ewes, tissues were incubated in the absence or presence of growth factors with or without meclofenamate (1 mu M). The stable metabolite of PGI(2), 6-keto-PGF(1 alpha), was measured in culture media and expressed as ng/mg wet wt * 24 h. PGI(2) production by UA increased (p < 0.05) from 5.43 +/- 0.26 at control to 8.93 +/- 0.99 with 100 ng/mL bFGF. Although VEGF produced a similar response, EGF did not increase PGI(2) production in UA. In pPA, 100 ng/mL bFGF induced a 2.2-fold increase (p < 0.01) in PGI(2) production from 1.94 +/- 0.14 to 4.20 +/- 0.31; VEGF and EGF were without effect. In tPA, 50 and 100 ng/mL bFGF increased PGI(2) production from 1.98 +/- 0.14 to 3.5 +/- 1.05 and 3.96 +/- 0.46 (p < 0.02). In tPA, VEGF did not increase PGI(2) production; however, 10, 50, and 100 ng/mL EGF, enhanced (p < 0.03) PGI(2) production from 1.98 +/- 0.14 to 3.39 +/- 0.62, 3.62 +/- 0.26, and 2.93 +/- 0.20. Endothelium removal and meclofenamate treatment caused a 90% and 100% decrease, respectively, in basal PGI(2) production, with no recovery after treatment with growth factors,We conclude that PGI(2) production is augmented by bFGF in UA, pPA and tPA, by VEGF in UA, and by EGF in tPA during ovine pregnancy. Basal and stimulated PGI(2) secretion is endothelium-derived via de novo synthesis, bFGF, VEGF, and EGF, in addition to angiogenesis, may modulate PGI(2) production, further enhancing blood flow to the growing uteroplacental bed. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 51 条
[41]  
RISTIMAKI A, 1988, THROMB HAEMOSTASIS, V59, P248
[42]   CIRCULATORY CHANGES DURING GROWTH IN FETAL LAMB [J].
RUDOLPH, AM ;
HEYMANN, MA .
CIRCULATION RESEARCH, 1970, 26 (03) :289-&
[43]   Nitric oxide and pregnancy [J].
Sladek, SM ;
Magness, RR ;
Conrad, KP .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1997, 272 (02) :R441-R463
[44]   ROLES OF PROSTAGLANDINS AND INTRACELLULAR FREE CALCIUM MOBILIZATION IN EPIDERMAL GROWTH FACTOR-INDUCED PROLIFERATION OF HUMAN AMNION CELLS [J].
TAHARA, M ;
MASUMOTO, N ;
MIZUKI, J ;
KASAHARA, K ;
TASAKA, K ;
KURACHI, H ;
MIYAKE, A .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (10) :894-900
[45]   EPIDERMAL GROWTH-FACTOR (EGF) AND TUMOR PROMOTER 12-0-TETRADECANOYLPHORBOL 13-ACETATE (TPA) STIMULATE PG SYNTHESIS AND THYMIDINE INCORPORATION IN CULTURED PORCINE THYROID-CELLS [J].
TAKASU, N ;
SATO, S ;
YAMADA, T ;
SHIMIZU, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 143 (03) :880-884
[46]   ANGIOGENESIS IN THE UTERUS - POTENTIAL REGULATION AND RELATION TO TUMOR ANGIOGENESIS [J].
TORRY, RJ ;
RONGISH, BJ .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1992, 27 (3-4) :171-179
[47]   Amniotic fluid epidermal growth factor levels in normal and abnormal pregnancies [J].
Varner, MW ;
Dildy, GA ;
Hunter, C ;
Dudley, DJ ;
Clark, SL ;
Mitchell, MD .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 1996, 3 (01) :17-19
[48]   Expression of vascular endothelial growth factor and placenta growth factor in human placenta [J].
Vuorela, P ;
Hatva, E ;
Lymboussaki, A ;
Kaipainen, A ;
Joukov, V ;
Persico, MG ;
Alitalo, K ;
Halmesmaki, E .
BIOLOGY OF REPRODUCTION, 1997, 56 (02) :489-494
[49]   IN-VIVO EFFECTS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR ON THE CHICKEN CHORIOALLANTOIC MEMBRANE [J].
WILTING, J ;
CHRIST, B ;
BOKELOH, M ;
WEICH, HA .
CELL AND TISSUE RESEARCH, 1993, 274 (01) :163-172
[50]   ANGIOTENSIN-II AND ALPHA-AGONIST .3. INVITRO FETAL-MATERNAL PLACENTAL PROSTAGLANDINS [J].
YOSHIMURA, T ;
ROSENFELD, CR ;
MAGNESS, RR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (01) :E8-E13